Insider Selling: Surgery Partners, Inc. (NASDAQ:SGRY) CFO Sells 13,641 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRY) CFO David T. Doherty sold 13,641 shares of the business’s stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.61, for a total value of $349,346.01. Following the transaction, the chief financial officer now owns 108,862 shares of the company’s stock, valued at approximately $2,787,955.82. The trade was a 11.14 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Surgery Partners Price Performance

SGRY stock opened at $25.75 on Wednesday. The firm has a market cap of $3.27 billion, a P/E ratio of -53.65, a P/E/G ratio of 17.77 and a beta of 2.60. The firm’s fifty day moving average is $21.88 and its 200 day moving average is $26.90. Surgery Partners, Inc. has a 52 week low of $19.50 and a 52 week high of $35.29. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $770.40 million for the quarter, compared to the consensus estimate of $768.99 million. During the same period last year, the business posted $0.15 earnings per share. The firm’s quarterly revenue was up 14.3% compared to the same quarter last year. Research analysts predict that Surgery Partners, Inc. will post 0.71 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on SGRY. Bank of America initiated coverage on Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 price target for the company. Macquarie reiterated an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a research report on Tuesday, November 19th. Royal Bank of Canada decreased their price target on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a report on Wednesday, November 20th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research report on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $36.56.

Hedge Funds Weigh In On Surgery Partners

Institutional investors and hedge funds have recently bought and sold shares of the stock. Principal Financial Group Inc. bought a new position in shares of Surgery Partners in the third quarter worth approximately $1,469,000. King Street Capital Management L.P. bought a new stake in Surgery Partners in the 3rd quarter worth $46,748,000. Royce & Associates LP increased its position in shares of Surgery Partners by 12.2% in the third quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock valued at $16,451,000 after acquiring an additional 55,545 shares during the period. Geode Capital Management LLC raised its stake in shares of Surgery Partners by 2.4% during the third quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock valued at $60,117,000 after acquiring an additional 42,897 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its holdings in shares of Surgery Partners by 140.4% during the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock worth $42,892,000 after purchasing an additional 777,038 shares during the period.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.